Viewing nowCombinationCorphazine 5/160 mg
Amlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.

MFDS item code 201702125 · Approved 2017.04.26 · Insurance code 054800040
Improvement in blood pressure control in essential hypertension through the combination of amlodipine and valsartan
This medicine helps achieve effective blood pressure control in patients with essential hypertension who have difficulty controlling blood pressure with monotherapy using amlodipine or valsartan. By stabilizing blood pressure, it is important for reducing the risk of cardiovascular diseases and maintaining health. This drug works by combining two components to dilate blood vessels and manage blood pressure effectively. It is used for the treatment of essential hypertension.
The recommended dose of this medication is 1 tablet once a day, taken with water regardless of meals. It is advised to take it at the same time each day (e.g., morning). It is administered in 5/80 mg, 5/160 mg, and 10/160 mg doses depending on blood pressure control status. For patients with mild to moderate renal impairment, no dosage adjustment is necessary; however, patients with severe renal impairment or those on dialysis should not be given this medication.
The safety and efficacy of this drug have not been established in pediatric patients under the age of 18, and its use is not recommended.
This drug may cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Patients with allergies to the active ingredient or related components, pregnant or nursing women, and those with severe kidney or liver disease should not use this medication. Patients with low sodium or fluid levels in the body may experience hypotension; therefore, their condition should be thoroughly checked before use, and blood pressure should be closely monitored during treatment. Patients with high potassium levels may experience increased potassium concentration when taking this drug with potassium-rich medications or supplements, so regular blood tests are necessary. Patients with renal vascular issues or those who have undergone kidney transplants should use this drug cautiously due to the risk of worsening kidney function. If symptoms of angioedema (swelling of the face, lips, tongue, etc.) occur while taking this drug, it should be discontinued immediately and medical attention sought. Patients with heart failure or post-myocardial infarction should closely monitor their kidney function and blood pressure while taking this drug, as pulmonary edema may occur in some cases, requiring caution. This drug may interact with other antihypertensive or specific medications, so if other medications are being taken, it is essential to inform a doctor or pharmacist. Caution is needed as dizziness or fatigue may occur while driving or operating machinery. In the case of overdose, severe hypotension or cardiac arrhythmias may occur, and immediate medical attention should be sought if symptoms arise. This drug is not recommended for children under the age of 18, as its safety and effectiveness have not been sufficiently established. For the elderly, it may be administered at similar dosages as in adults, but their physical condition should be carefully monitored.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rash with high fever, blisters, peeling skin, mucosal pain in the mouth/eyes, severe skin adverse reactions, difficulty breathing or shortness of breath, asthma attacks, cough with fever and respiratory abnormalities, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and severe headache.
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a sealed container as it may be sensitive to air or moisture. It is best to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage will maintain the drug's effectiveness for a longer period.
Dark yellow oval film-coated tablet
28 tablets/box [(14 tablets/Alu-Alu X2)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.